Vera Therapeutics, Inc. (VERA) - Quarterly Income Statement

Home
VERA
Financials

30.63 (USD) • At close June 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0	-0.952	-0.635	0	0	-0.506	0	0	0	0.009	0.032	0.059	0.05	0.035	0	0	0	0
Gross Profit Numbers are in millions	0	0	0	0	0.952	0.635	0	0	0.506	0	0	0	-0.009	-0.032	-0.059	-0.05	-0.035	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	41.278	33.347	40.314	29.311	24.669	21.952	16.1	16.231	25.108	26.676	19.656	10.112	12.549	12.753	3.564	3.235	2.932	39.844	1.969	1.954	1.439
General & Administrative Expenses Numbers are in millions	15.916	15.567	9.487	8.032	7.912	6.243	5.656	5.739	6.15	6.905	5.588	4.945	4.472	3.832	3.688	2.614	1.784	1.136	0.652	1.219	1.032
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	-0.517	-0.532	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	15.916	15.567	9.487	8.032	7.395	5.711	5.656	5.739	6.15	6.905	5.588	4.945	4.472	3.832	3.688	2.614	1.784	1.136	0.652	1.219	1.032
Other Expenses Numbers are in millions	0	0	0	0.45	0.453	0.472	1.652	0.511	1.189	0.912	0.347	0.325	0.315	-0.261	0	0	0	-0.301	-0.359	-0.369	-0.047
Operating Expenses Numbers are in millions	57.194	48.914	49.801	37.343	32.064	27.663	21.756	21.97	31.258	33.581	25.244	15.057	17.021	16.585	7.252	5.849	4.716	40.98	2.621	3.173	2.471
Operating Income Numbers are in millions	-57.194	-48.914	-49.801	-37.343	-31.112	-27.028	-21.756	-21.97	-31.258	-33.581	-25.244	-15.057	-17.021	-16.585	-7.252	-5.849	-4.716	-42.56	-4.037	-3.173	-2.471
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	5.5	5.49	3.169	3.635	2.729	1.374	1.652	1.808	1.189	1.143	0.565	0.204	-0.064	-0.261	-0.359	2.412	0.002	-0.314	-0.423	-0.431	-0.003
Income Before Tax Numbers are in millions	-51.694	-43.424	-46.632	-33.708	-28.383	-25.654	-20.104	-20.162	-30.069	-32.438	-24.679	-14.853	-17.085	-16.846	-7.611	-3.437	-4.714	-42.874	-4.46	-3.604	-2.474
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0.001	0	0	-0.995	0.001	1.442	2.396	-0.315	0.001	-0.565	0.559	0.064	0.001	0.359	-2.412	-0.002	2.223	0.423	0.431	0.003
Net Income Numbers are in millions	-51.694	-43.425	-46.632	-33.708	-28.383	-25.655	-20.104	-20.162	-29.754	-32.439	-24.114	-14.853	-17.149	-16.847	-7.611	-3.437	-4.714	-42.875	-4.46	-3.604	-2.474
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.81	-0.85	-0.85	-0.62	-0.56	-0.58	-0.45	-0.46	-0.79	-1.17	-0.89	-0.55	-0.71	-0.79	-0.36	-0.33	-0.23	-2.09	-1.09	-0.88	-0.61
EPS Diluted Numbers are in millions	-0.81	-0.85	-0.85	-0.62	-0.56	-0.58	-0.45	-0.46	-0.79	-1.17	-0.89	-0.55	-0.71	-0.79	-0.36	-0.33	-0.23	-2.09	-1.09	-0.88	-0.61
EBITDA Numbers are in millions	-57.194	-41.498	-44.672	-31.796	-27.429	-27.161	-21.756	-19.248	-29.701	-31.839	-25.244	-15.057	-16.958	-16.794	-7.552	-3.387	-4.679	-42.859	-4.396	-3.429	-2.342
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Vera Therapeutics, Inc.

NASDAQ:VERA Add to watchlist

NASDAQ:VERA